의료기기관련기관/국가임상시험지원재단
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 05.19(금)
toucrew
2023. 8. 18. 15:18
반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/ 바이오/ 임상시험 |
Thematic Intelligence: Immuno-oncology (2023) |
05-10-2023 |
| ImmunoGen’s Drug Elahere Offers Hope for Ovarian Cancer Patients |
05-10-2023 | |
| Ultragenyx’s Phase I/II Study for mRNA Therapeutic Terminated |
05-05-2023 | |
| Contract Manufacturing: Opportunities and Threats – April 2023 |
05-02-2023 | |
| April Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2023 |
05-02-2023 | |
| Oncology Drug Sales Expected to Generate $2.2 Trillion by 2029 |
05-02-2023 | |
| Contract Service Agreements – April 2023 |
05-02-2023 | |
| Bio/Pharmaceutical Outsourcing Report, April 2023 |
04-28-2023 | |
| A Broad Range of Unmet Needs Remains in the Immuno-Oncology Space |
04-28-2023 | |
| APAC Leads in Trials for 2022, with the Majority in Phase II |
04-28-2023 | |
| Novo Nordisk Blockbuster Ozempic Boasts 23% Sales Surge in 2023 |
04-28-2023 | |
| First Allogeneic Stem Cell Therapy Approval to Pave the Way for Future Therapies in This Class |
04-28-2023 | |
| 질환별 | Myocardial Infarction: Competitive Landscape |
04-30-2023 |
| Melanoma: Cell & Gene Therapies 15-Market Assessment and Forecast |
04-28-2023 | |
| Ovarian Cancer: Cell & Gene Therapies 15-Market Assessment and Forecast |
04-28-2023 | |
반응형